SYRE

Spyre Therapeutics Inc

May 15 • 04:00PM ET

74.92

-0.73 -0.96 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: LKFT ROIV APLS VERA KYMR

| Held by: IWM VTI XBI VXF IBB IWO SCHA VTWO IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	12.10%	Shs Outstand	78.84M	Perf Week	-0.17%
Market Cap	6.51B	Forward P/E	-	EPS next Y	-3.13	Insider Trans	-2.58%	Shs Float	76.33M	Perf Month	7.49%
Enterprise Value	5.92B	PEG	-	EPS next Q	-0.73	Inst Own	84.76%	Short Float	16.01%	Perf Quarter	104.53%
Income	-168.74M	P/S	-	EPS this Y	-46.88%	Inst Trans	23.44%	Short Ratio	11.25	Perf Half Y	219.76%
Sales	0.00M	P/B	11.47	EPS next Y	-7.68%	ROA	-25.30%	Short Interest	12.22M	Perf YTD	128.69%
Book/sh	6.53	P/C	8.77	EPS next 5Y	-22.06%	ROE	-29.26%	52W High	78.80 -4.92%	Perf Year	415.27%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 437.83%	Perf 3Y	1981.11%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.63% 5.85%	Perf 5Y	-60.36%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.22	Perf 10Y	-58.20%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	63.69	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	3.16%	Beta	3.09	Target Price	95.20
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	28.12%	Rel Volume	1.80	Prev Close	75.65
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	119.88%	Avg Volume	1.09M	Price	74.92
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	1,957,575	Change	-0.96%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)